Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Olema Oncology granted stock options to eight new employees to purchase 215,800 shares of common stock. The awards were made under the 2022 Inducement Plan in accordance with Nasdaq Listing Rule 5635(c)(4), effective July 1, 2026.
Key figures
- Offering Price
- 12.08
- Shares Offered
- 215800
- Employee count
- 8
- Option term years
- 10
- Vesting period years
- 4
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.